A nano-cocktail of an NIR-II emissive fluorophore and organoplatinum(<scp>ii</scp>) metallacycle for efficient cancer imaging and therapy

Abstract

A novel NIR-II theranostic nanoprobe, <bold>PSY</bold> (∼110 nm), was concisely developed, which demonstrated excellent photostability, high tumor uptake, superior S/N ratios and more efficient cancer treatment with minimal side effects than cisplatin.